<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font24 { font-size : 24; } .font29 { font-size : 29; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">cells </span>
   <span class="font29">expression </span>
   <span class="font24">antiviral </span>
   <span class="font22">HERV </span>
   <span class="font21">endogenous </span>
   <span class="font20">human </span>
   <span class="font19">drugs </span>
   <span class="font18">using </span>
   <span class="font18">elements </span>
   <span class="font18">{border-style </span>
   <span class="font17">compounds </span>
   <span class="font17">HCTRETO </span>
   <span class="font17">HERVs </span>
   <span class="font17">cell </span>
   <span class="font17">px;} </span>
   <span class="font17">#ffffff;} </span>
   <span class="font17">activity </span>
   <span class="font17">amantadine </span>
   <span class="font17">colon </span>
   <span class="font16">cancer </span>
   <span class="font16">cells. </span>
   <span class="font16">tumor </span>
   <span class="font15">HCTWT/RETO </span>
   <span class="font15">HERV-WE </span>
   <span class="font15">analyzed </span>
   <span class="font15">protein </span>
   <span class="font15">carcinoma </span>
   <span class="font15">chemotherapy </span>
   <span class="font15">(Fig. </span>
   <span class="font15">amantadine, </span>
   <span class="font15">colorectal </span>
   <span class="font15">data </span>
   <span class="font15">proteins </span>
   <span class="font15">retrovirus </span>
   <span class="font15">ribavirin </span>
   <span class="font14">Fig. </span>
   <span class="font14">HCT </span>
   <span class="font14">HERV-FRD </span>
   <span class="font14">pleconaril </span>
   <span class="font14">resistance </span>
   <span class="font14">washed </span>
   <span class="font14">HCTWT </span>
   <span class="font14">combination </span>
   <span class="font14">minutes </span>
   <span class="font14">stem </span>
   <span class="font14">viral </span>
   <span class="font13">Germany) </span>
   <span class="font13">[]. </span>
   <span class="font13">antibodies </span>
   <span class="font13">anticancer </span>
   <span class="font13">breast </span>
   <span class="font13">cells, </span>
   <span class="font13">described </span>
   <span class="font13">different </span>
   <span class="font13">independent </span>
   <span class="font13">reported </span>
   <span class="font13">samples </span>
   <span class="font13">PBS </span>
   <span class="font13">RNA </span>
   <span class="font13">effect </span>
   <span class="font13">expressed </span>
   <span class="font13">hours. </span>
   <span class="font13">incubation </span>
   <span class="font13">normal </span>
   <span class="font13">patient </span>
   <span class="font13">px; </span>
   <span class="font13">synergistic </span>
   <span class="font13">{font-family </span>
   <span class="font12">Biological </span>
   <span class="font12">MTT </span>
   <span class="font12">according </span>
   <span class="font12">buffer </span>
   <span class="font12">corrections. </span>
   <span class="font12">cytostatics </span>
   <span class="font12">cytotoxic </span>
   <span class="font12">determined </span>
   <span class="font12">development </span>
   <span class="font12">drug </span>
   <span class="font12">enhanced </span>
   <span class="font12">font-size </span>
   <span class="font12">highly </span>
   <span class="font12">incubated </span>
   <span class="font12">interaction </span>
   <span class="font12">n =  </span>
   <span class="font12">performed </span>
   <span class="font12">retroviruses </span>
   <span class="font12">revision </span>
   <span class="font12">sections </span>
   <span class="font12">used </span>
   <span class="font12">(panel </span>
   <span class="font12">USA). </span>
   <span class="font12">antiproliferative </span>
   <span class="font12">article </span>
   <span class="font12">chemoresistant </span>
   <span class="font12">cytotoxicity </span>
   <span class="font12">double; </span>
   <span class="font12">etoposide </span>
   <span class="font12">express </span>
   <span class="font12">like </span>
   <span class="font12">potential </span>
   <span class="font12">results </span>
   <span class="font12">retroviral </span>
   <span class="font12">serum </span>
   <span class="font12">studies, </span>
   <span class="font12">times </span>
   <span class="font12">transcripts </span>
   <span class="font12">tumors </span>
   <span class="font12">values </span>
   <span class="font12">vitro </span>
   <span class="font12">Article </span>
   <span class="font12">Briefly, </span>
   <span class="font12">Cancer </span>
   <span class="font12">Clin </span>
   <span class="font12">Differential </span>
   <span class="font12">Results </span>
   <span class="font12">Tween </span>
   <span class="font12">[–]. </span>
   <span class="font12">acquisition. </span>
   <span class="font12">adenocarcinoma </span>
   <span class="font12">agents </span>
   <span class="font12">analysis </span>
   <span class="font12">associated </span>
   <span class="font12">border-color </span>
   <span class="font12">border-width </span>
   <span class="font12">carcinomas </span>
   <span class="font12">compared </span>
   <span class="font12">cytostatic </span>
   <span class="font12">downregulation </span>
   <span class="font12">effects </span>
   <span class="font12">experiments </span>
   <span class="font12">gene </span>
   <span class="font12">growth </span>
   <span class="font12">levels </span>
   <span class="font12">observed </span>
   <span class="font12">obtained </span>
   <span class="font12">overexpressed </span>
   <span class="font12">previously </span>
   <span class="font12">primers </span>
   <span class="font12">proliferation </span>
   <span class="font12">refractory </span>
   <span class="font12">relationship </span>
   <span class="font12">role </span>
   <span class="font12">shown </span>
   <span class="font12">slides </span>
   <span class="font12">solid; </span>
   <span class="font12">targeting </span>
   <span class="font12">tissues </span>
   <span class="font12">{font-style </span>
   <span class="font12">{font-weight </span>
   <span class="font11">California, </span>
   <span class="font11">Cell </span>
   <span class="font11">Enhanced </span>
   <span class="font11">FRD </span>
   <span class="font11">Germany). </span>
   <span class="font11">Germany. </span>
   <span class="font11">HERV-K </span>
   <span class="font11">HERV-V </span>
   <span class="font11">Pharmacol </span>
   <span class="font11">Western </span>
   <span class="font11">acute </span>
   <span class="font11">addition, </span>
   <span class="font11">applied </span>
   <span class="font11">appropriate </span>
   <span class="font11">assay. </span>
   <span class="font11">bold </span>
   <span class="font11">cisplatin </span>
   <span class="font11">concentrations </span>
   <span class="font11">courier; </span>
   <span class="font11">demonstrated </span>
   <span class="font11">detectable </span>
   <span class="font11">eIFE </span>
   <span class="font11">em; </span>
   <span class="font11">env </span>
   <span class="font11">envelope </span>
   <span class="font11">especially </span>
   <span class="font11">exposure </span>
   <span class="font11">genome </span>
   <span class="font11">instructions. </span>
   <span class="font11">known </span>
   <span class="font11">leukemia </span>
   <span class="font11">line </span>
   <span class="font11">manufacturer’s </span>
   <span class="font11">measured </span>
   <span class="font11">medium </span>
   <span class="font11">minutes. </span>
   <span class="font11">myeloid </span>
   <span class="font11">number </span>
   <span class="font11">overexpression </span>
   <span class="font11">overnight </span>
   <span class="font11">panel </span>
   <span class="font11">pt;} </span>
   <span class="font11">purchased </span>
   <span class="font11">represent </span>
   <span class="font11">resistant </span>
   <span class="font11">respective </span>
   <span class="font11">secondary </span>
   <span class="font11">significant </span>
   <span class="font11">significantly </span>
   <span class="font11">simultaneously </span>
   <span class="font11">vitro. </span>
   <span class="font11">wells </span>
  </p>
 </body>
</html>
